anonymous
Guest
anonymous
Guest
Rumors are that based on the fine job ADG has done over seas and the fact we need more minority children in top spots, (as is the case with all of pharma), ADG will be our Gal. Since DD left years back for Glaxo, now back in PR. Lilly has had a huge void. Lilly’s new VP will be ADG. How do people feel about this. Please know this is not a trial ballon but a possibility based on human r possibilities.
Is ADG smart enough for this huge jump?.
Is ADG smart enough for this huge jump?.